Notice for trosovavilp alfa (Biocelect Pty Ltd)
Active ingredients
trosovavilp alfa
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
For active immunisation for the prevention of disease caused by chikungunya virus (CHIKV) in adults and children aged 12 years and older. The use of this vaccine should be in accordance with official recommendations
Therapeutic area
Vaccines